Behavioral defects in chaperone-deficient Alzheimer's disease model mice.
Molecular chaperones protect cells from the deleterious effects of protein misfolding and aggregation. Neurotoxicity of amyloid-beta (Aβ) aggregates and their deposition in senile plaques are hallmarks of Alzheimer's disease (AD). We observed that the overall content of αB-crystallin, a small h...
Main Authors: | Juhi Ojha, Rajalakshmi V Karmegam, J Gunasingh Masilamoni, Alvin V Terry, Anil G Cashikar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3040748?pdf=render |
Similar Items
-
The Chaperonopathies - Diseases with Defective Molecular Chaperones
by: Giovanni Li Volti
Published: (2013-10-01) -
Potential of molecular chaperones for treating Alzheimer’s disease
by: Gefei Chen, et al.
Published: (2024-01-01) -
Late onset motoneuron disorder caused by mitochondrial Hsp60 chaperone deficiency in mice
by: Raffaella Magnoni, et al.
Published: (2013-06-01) -
Brain morphological defects in prolidase deficient mice: first report
by: V. Insolia, et al.
Published: (2014-09-01) -
Behavioral phenotyping of Kaiso-deficient mice
by: V. S. Korostina, et al.
Published: (2015-12-01)